154 related articles for article (PubMed ID: 26718507)
1. Tripartite motif 16 suppresses breast cancer stem cell properties through regulation of Gli-1 degradation via the ubiquitin-proteasome pathway.
Yao J; Xu T; Tian T; Fu X; Wang W; Li S; Shi T; Suo A; Ruan Z; Guo H; Yao Y
Oncol Rep; 2016 Feb; 35(2):1204-12. PubMed ID: 26718507
[TBL] [Abstract][Full Text] [Related]
2. TRIM16 overexpression inhibits the metastasis of colorectal cancer through mediating Snail degradation.
Ruan L; Liu W; Yang Y; Chu Z; Yang C; Yang T; Sun J
Exp Cell Res; 2021 Sep; 406(1):112735. PubMed ID: 34265287
[TBL] [Abstract][Full Text] [Related]
3. TRIM16 suppresses the progression of prostate tumors by inhibiting the Snail signaling pathway.
Qi L; Lu Z; Sun YH; Song HT; Xu WK
Int J Mol Med; 2016 Dec; 38(6):1734-1742. PubMed ID: 27748839
[TBL] [Abstract][Full Text] [Related]
4. Tripartite motif 16 inhibits hepatocellular carcinoma cell migration and invasion.
Li L; Dong L; Qu X; Jin S; Lv X; Tan G
Int J Oncol; 2016 Apr; 48(4):1639-49. PubMed ID: 26892350
[TBL] [Abstract][Full Text] [Related]
5. High TDP43 expression is required for TRIM16-induced inhibition of cancer cell growth and correlated with good prognosis of neuroblastoma and breast cancer patients.
Kim PY; Tan O; Liu B; Trahair T; Liu T; Haber M; Norris MD; Marshall GM; Cheung BB
Cancer Lett; 2016 May; 374(2):315-23. PubMed ID: 26902425
[TBL] [Abstract][Full Text] [Related]
6. Tripartite Motif 16 Inhibits the Migration and Invasion in Ovarian Cancer Cells.
Tan H; Qi J; Chu G; Liu Z
Oncol Res; 2017 Apr; 25(4):551-558. PubMed ID: 27737724
[TBL] [Abstract][Full Text] [Related]
7. RING finger protein 31 promotes p53 degradation in breast cancer cells.
Zhu J; Zhao C; Zhuang T; Jonsson P; Sinha I; Williams C; Strömblad S; Dahlman-Wright K
Oncogene; 2016 Apr; 35(15):1955-64. PubMed ID: 26148235
[TBL] [Abstract][Full Text] [Related]
8. TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells.
Kim PY; Rahmanto AS; Tan O; Norris MD; Haber M; Marshall GM; Cheung BB
Apoptosis; 2013 May; 18(5):639-51. PubMed ID: 23404198
[TBL] [Abstract][Full Text] [Related]
9. TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other TRIM family members.
Bell JL; Malyukova A; Holien JK; Koach J; Parker MW; Kavallaris M; Marshall GM; Cheung BB
PLoS One; 2012; 7(5):e37470. PubMed ID: 22629402
[TBL] [Abstract][Full Text] [Related]
10. TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization.
Bell JL; Malyukova A; Kavallaris M; Marshall GM; Cheung BB
Cell Cycle; 2013 Mar; 12(6):889-98. PubMed ID: 23422002
[TBL] [Abstract][Full Text] [Related]
11. Tripartite motif 16 inhibits epithelial-mesenchymal transition and metastasis by down-regulating sonic hedgehog pathway in non-small cell lung cancer cells.
Huo X; Li S; Shi T; Suo A; Ruan Z; Yao Y
Biochem Biophys Res Commun; 2015 May; 460(4):1021-8. PubMed ID: 25843803
[TBL] [Abstract][Full Text] [Related]
12. TRIM16 inhibits proliferation and migration through regulation of interferon beta 1 in melanoma cells.
Sutton SK; Koach J; Tan O; Liu B; Carter DR; Wilmott JS; Yosufi B; Haydu LE; Mann GJ; Thompson JF; Long GV; Liu T; McArthur G; Zhang XD; Scolyer RA; Cheung BB; Marshall GM
Oncotarget; 2014 Oct; 5(20):10127-39. PubMed ID: 25333256
[TBL] [Abstract][Full Text] [Related]
13. The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro.
Cheung BB; Koach J; Tan O; Kim P; Bell JL; D'andreti C; Sutton S; Malyukova A; Sekyere E; Norris M; Haber M; Kavallaris M; Cunningham AM; Proby C; Leigh I; Wilmott JS; Cooper CL; Halliday GM; Scolyer RA; Marshall GM
J Pathol; 2012 Feb; 226(3):451-62. PubMed ID: 22009481
[TBL] [Abstract][Full Text] [Related]
14. TRIM16 controls assembly and degradation of protein aggregates by modulating the p62-NRF2 axis and autophagy.
Jena KK; Kolapalli SP; Mehto S; Nath P; Das B; Sahoo PK; Ahad A; Syed GH; Raghav SK; Senapati S; Chauhan S; Chauhan S
EMBO J; 2018 Sep; 37(18):. PubMed ID: 30143514
[TBL] [Abstract][Full Text] [Related]
15. TRIM3 and TRIM16 as potential tumor suppressors in breast cancer patients.
Roshanazadeh MR; Adelipour M; Sanaei A; Chenane H; Rashidi M
BMC Res Notes; 2022 Sep; 15(1):312. PubMed ID: 36180926
[TBL] [Abstract][Full Text] [Related]
16. TRIM32/USP11 Balances ARID1A Stability and the Oncogenic/Tumor-Suppressive Status of Squamous Cell Carcinoma.
Luo Q; Wu X; Nan Y; Chang W; Zhao P; Zhang Y; Su D; Liu Z
Cell Rep; 2020 Jan; 30(1):98-111.e5. PubMed ID: 31914402
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin ligase CHIP suppresses cancer stem cell properties in a population of breast cancer cells.
Tsuchiya M; Nakajima Y; Hirata N; Morishita T; Kishimoto H; Kanda Y; Kimura K
Biochem Biophys Res Commun; 2014 Oct; 452(4):928-32. PubMed ID: 25234599
[TBL] [Abstract][Full Text] [Related]
18. RNF144A suppresses ovarian cancer stem cell properties and tumor progression through regulation of LIN28B degradation via the ubiquitin-proteasome pathway.
Li Y; Wang J; Wang F; Chen W; Gao C; Wang J
Cell Biol Toxicol; 2022 Oct; 38(5):809-824. PubMed ID: 33978933
[TBL] [Abstract][Full Text] [Related]
19. TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells.
Marshall GM; Bell JL; Koach J; Tan O; Kim P; Malyukova A; Thomas W; Sekyere EO; Liu T; Cunningham AM; Tobias V; Norris MD; Haber M; Kavallaris M; Cheung BB
Oncogene; 2010 Nov; 29(46):6172-83. PubMed ID: 20729920
[TBL] [Abstract][Full Text] [Related]
20. Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.
Guo Y; Li Q; Zhao G; Zhang J; Yuan H; Feng T; Ou D; Gu R; Li S; Li K; Lin P
Cell Death Dis; 2021 Oct; 12(10):945. PubMed ID: 34650049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]